Navigation Links
Despite Availability of Generic Equivalents, Two-Thirds of Neurologists Will Continue to Prescribe Branded Anti-Epileptic Drugs to Epilepsy Patients

However, AED Brands Facing Generic Competition Will be Dropped or Pushed to Tier Three of Many MCO Formularies, According to a New Report from Decision Resources

WALTHAM, Mass., Jan. 5 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the willingness of neurologists to prescribe generic anti-epileptic drugs (AEDs) varies dramatically by indication, affording branded AEDs protection in the epilepsy market but not in other markets. Despite physicians' misgivings about the generic equivalence of AEDs, 89 percent of surveyed neurologists are willing to prescribe generic AEDs for painful diabetic neuropathy, and 84 percent are willing to prescribe AEDs for migraine prophylaxis. By contrast, only about one-third of neurologists are willing to prescribe generic AEDs for patients with partial onset epilepsy or refractory epilepsy.

The new Physician & Payer Forum report Will Prescribers and Payers Allow Branded AEDs to Stem the Tide of Generics in Epilepsy, Migraine, Neuropathic Pain or Bipolar Disorder? finds that while physicians' determination to resist generic substitution of branded AEDs at the pharmacy level varies hugely by indication, it does not vary as significantly by brand.

"Currently, 54 percent of the neurologists we surveyed specify 'no generic substitution' on prescriptions for GlaxoSmithKline's Lamictal and a similar proportion indicate they will specify the same on prescriptions for other AEDs when generic versions of these agents become available," said Kate Hohenberg, director at Decision Resources. "However, there is an exception, most significantly in epilepsy, for Abbott's Depakote ER. Our survey showed that 79 percent of neurologists will not agree to switch their epilepsy patients from the brand to the generic version of Depakote ER. Physicians' concerns are a result of this agent's narrower therapeutic index and its narrower margin for error in generic equivalence."

The report also finds that brands facing generic competition will be dropped or pushed to tier three of many managed care organizations' (MCO) formularies. After March 2009, when generic versions of UCB's Keppra, Ortho-McNeil's Topamax and Depakote ER have become available, more than half of 20 surveyed private plans will remove Keppra and Topamax from their formularies and another five plans will shift these brands to tier three. By contrast, Depakote ER will retain favorable placement in 50 percent of surveyed plans.

Will Prescribers and Payers Allow Branded AEDs to Stem the Tide of Generics in Epilepsy, Migraine, Neuropathic Pain or Bipolar Disorder? is based on a U.S. survey of 70 psychiatrists and 70 neurologists and 20 MCO pharmacy directors. Their responses were compared to assess similarities and differences of opinion regarding clinical, economic and scientific factors.

About Decision Resources

Decision Resources ( is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

    Decision Resources
    Christopher Comfort

    Decision Resources, Inc.
    Elizabeth Marshall

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Despite Sagging Economy, Viamedic Reports Solid Online Sales for Erectile Dysfunction Drugs
2. Coerced medication used in psychiatric care despite lack of clinical evidence
3. Jennie Finch Shares how to Fire up the Romance Despite the Demands of the Holidays
4. Hopes for AIDS Vaccine Still Alive Despite Setbacks
5. Despite Economy, Oregon Wine Benefit !Salud! Raises Over $735,000
6. Despite national guidelines, private insurers, ER, federal and state agencies fail to routinely test for HIV
7. Triglyceride Levels Continue to Rise in the United States Despite Increased Use of Cholesterol-Lowering Medications
8. Bone cancer treatment ineffective, despite promising laboratory data
9. Despite U.S. economy, more Americans seeking cosmetic surgery overseas
10. Despite Credit Crunch, Medisave Sees Strong Sales Increase in 2008
11. Stroller Strides(R) Franchises Succeed Despite Economic Climate
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
(Date:6/24/2016)... -- Research and Markets has announced ... Applications, Technologies, Forecasts" report to their offering. ... Smart Skin, Structural Health Monitoring, Composite Smart Structures, ... involves electronic and/or electrical components and circuits that ... such as vehicle bodies or conformally placed upon ...
Breaking Medicine Technology: